Ari Ristimäki

1.8k total citations · 1 hit paper
18 papers, 1.5k citations indexed

About

Ari Ristimäki is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, Ari Ristimäki has authored 18 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Genetics. Recurrent topics in Ari Ristimäki's work include Inflammatory mediators and NSAID effects (5 papers), Estrogen and related hormone effects (4 papers) and Esophageal Cancer Research and Treatment (3 papers). Ari Ristimäki is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Estrogen and related hormone effects (4 papers) and Esophageal Cancer Research and Treatment (3 papers). Ari Ristimäki collaborates with scholars based in Finland, Sweden and United States. Ari Ristimäki's co-authors include Matti Härkönen, Heidi Jänkälä, P. Sipponen, Kirsi Narko, Olli Ritvos, Alexandra Thiel, Caj Haglund, Johan Lundin, Karri Paavonen and Mika Laitinen and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer Research and Oncogene.

In The Last Decade

Ari Ristimäki

14 papers receiving 1.5k citations

Hit Papers

Expression of cyclooxygenase-2 in human gastric carcinoma. 1997 2026 2006 2016 1997 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ari Ristimäki Finland 11 690 565 457 305 276 18 1.5k
Felicita Baratelli United States 16 366 0.5× 348 0.6× 172 0.4× 191 0.6× 85 0.3× 20 1.7k
Seok-Chul Yang South Korea 15 285 0.4× 347 0.6× 125 0.3× 189 0.6× 112 0.4× 23 1.6k
Masayuki Shiseki Japan 21 109 0.2× 960 1.7× 161 0.4× 302 1.0× 97 0.4× 53 1.6k
Uwe Trefzer Germany 19 173 0.3× 618 1.1× 175 0.4× 105 0.3× 67 0.2× 43 1.5k
M. Kay Washington United States 20 105 0.2× 738 1.3× 224 0.5× 284 0.9× 383 1.4× 34 1.6k
JI Kurland United States 12 322 0.5× 343 0.6× 142 0.3× 89 0.3× 85 0.3× 12 1.5k
David G. Alleva United States 21 109 0.2× 431 0.8× 435 1.0× 145 0.5× 276 1.0× 33 1.8k
Mark Van Oene Canada 9 139 0.2× 292 0.5× 550 1.2× 46 0.2× 268 1.0× 9 1.3k
John F. Penrose United States 22 500 0.7× 540 1.0× 111 0.2× 65 0.2× 193 0.7× 27 2.2k
Elias Gounaris United States 18 72 0.1× 637 1.1× 127 0.3× 148 0.5× 161 0.6× 27 1.5k

Countries citing papers authored by Ari Ristimäki

Since Specialization
Citations

This map shows the geographic impact of Ari Ristimäki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ari Ristimäki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ari Ristimäki more than expected).

Fields of papers citing papers by Ari Ristimäki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ari Ristimäki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ari Ristimäki. The network helps show where Ari Ristimäki may publish in the future.

Co-authorship network of co-authors of Ari Ristimäki

This figure shows the co-authorship network connecting the top 25 collaborators of Ari Ristimäki. A scholar is included among the top collaborators of Ari Ristimäki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ari Ristimäki. Ari Ristimäki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Räsänen, Jari, Olli Helminen, Mika Helmiö, et al.. (2025). Surgical complications after minimally invasive oesophagectomy compared to open oesophagectomy for oesophageal cancer: A population-based, nationwide study in Finland. European Journal of Surgical Oncology. 51(7). 110093–110093.
2.
Sur, Inderpreet, Jilin Zhang, Anna Webb, et al.. (2025). Shared requirement for MYC upstream super-enhancer region in tissue regeneration and cancer. Life Science Alliance. 8(6). e202403090–e202403090.
3.
Räsänen, Jari, Olli Helminen, Mika Helmiö, et al.. (2025). Neoadjuvant Treatment and Postoperative Complications After Surgery for Esophageal Cancer: A Population-Based, Nationwide Study in Finland. Annals of Surgical Oncology. 32(10). 7914–7928.
4.
Kytölä, Soili, Erdoğan Pekcan Erkan, Maarit Ahtiainen, et al.. (2025). Performance Comparison of Droplet Digital PCR and Next‐Generation Sequencing for Circulating Tumor DNA Detection in Non‐Metastatic Rectal Cancer. Cancer Medicine. 14(9). e70943–e70943. 2 indexed citations
5.
Ristimäki, Ari, Harri Mustonen, Jaana Hagström, et al.. (2022). β-catenin plus PROX1 immunostaining stratifies disease progression and patient survival in neoadjuvant-treated pancreatic cancer. Tumor Biology. 44(1). 69–84.
6.
Helminen, Olli, Mika Helmiö, Heikki Huhta, et al.. (2022). Five-year Survival after McKeown Compared to Ivor-Lewis Esophagectomy for Esophageal Cancer. Annals of Surgery. 277(6). 964–970. 6 indexed citations
7.
Ainola, Mari, Beata Przybyla, Vesa‐Petteri Kouri, et al.. (2015). Diminished salivary epidermal growth factor secretion: a link between Sjögren’s syndrome and autoimmune gastritis?. Scandinavian Journal of Rheumatology. 45(2). 118–121. 7 indexed citations
8.
Thiel, Alexandra & Ari Ristimäki. (2012). Gastric Cancer: Basic Aspects. Helicobacter. 17(s1). 26–29. 50 indexed citations
9.
Heinonen, Mira, Petri Bono, Kirsi Narko, et al.. (2005). Cytoplasmic HuR Expression Is a Prognostic Factor in Invasive Ductal Breast Carcinoma. Cancer Research. 65(6). 2157–2161. 184 indexed citations
10.
Mrena, Johanna, Jan‐Patrik Wiksten, Alexandra Thiel, et al.. (2005). Cyclooxygenase-2 Is an Independent Prognostic Factor in Gastric Cancer and Its Expression Is Regulated by the Messenger RNA Stability Factor HuR. Clinical Cancer Research. 11(20). 7362–7368. 129 indexed citations
11.
Bízik, Jozef, Esko Kankuri, Ari Ristimäki, et al.. (2003). Cell–cell contacts trigger programmed necrosis and induce cyclooxygenase-2 expression. Cell Death and Differentiation. 11(2). 183–195. 65 indexed citations
12.
Ekman, Niklas, Elena Arighi, Iiro Rajantie, et al.. (2000). The Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent manner. Oncogene. 19(36). 4151–4158. 35 indexed citations
13.
Saukkonen, Kirsi, et al.. (2000). Expression of Cyclooxygenase-2 and Prostanoid Receptors by Human Myometrium*. The Journal of Clinical Endocrinology & Metabolism. 85(9). 3468–3475. 81 indexed citations
14.
Narko, Kirsi, Olli Ritvos, & Ari Ristimäki. (1997). Induction of Cyclooxygenase-2 and Prostaglandin FReceptor Expression by Interleukin-1β in Cultured Human Granulosa-Luteal Cells1. Endocrinology. 138(9). 3638–3644. 72 indexed citations
15.
Ristimäki, Ari, Risto Jaatinen, & Olli Ritvos. (1997). Regulation of Prostaglandin FReceptor Expression in Cultured Human Granulosa-Luteal Cells1. Endocrinology. 138(1). 191–195. 36 indexed citations
17.
Ristimäki, Ari, et al.. (1997). Expression of cyclooxygenase-2 in human gastric carcinoma.. PubMed. 57(7). 1276–80. 714 indexed citations breakdown →
18.
Parkkinen, J, Ari Ristimäki, & Benita Westerlund‐Wikström. (1989). Binding of Escherichia coli S fimbriae to cultured human endothelial cells. Infection and Immunity. 57(7). 2256–2259. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026